[
  {
    "ts": "2025-11-04T23:27:00+00:00",
    "headline": "Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149",
    "summary": "Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.",
    "url": "https://www.wsj.com/health/pharma/trump-negotiating-deal-with-ozempic-maker-to-sell-some-weight-loss-drugs-for-149-1eb49286?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "3f324ce1-f4db-30b9-afd7-39feb7459eb7",
      "content": {
        "id": "3f324ce1-f4db-30b9-afd7-39feb7459eb7",
        "contentType": "STORY",
        "title": "Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149",
        "description": "",
        "summary": "Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.",
        "pubDate": "2025-11-04T23:27:00Z",
        "displayTime": "2025-11-04T23:27:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3f324ce1-f4db-30b9-afd7-39feb7459eb7/trump-negotiating-deal-with.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/53b0741bf30f1e62f41e03c5e19052ef",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eVv5MZZeVMXBiZ7sgiw0XQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/53b0741bf30f1e62f41e03c5e19052ef.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmH1qhw4TRMdlOyNC2ZUbA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/53b0741bf30f1e62f41e03c5e19052ef.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/trump-negotiating-deal-with-ozempic-maker-to-sell-some-weight-loss-drugs-for-149-1eb49286?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T21:30:00+00:00",
    "headline": "Novo Nordisk Reports Earnings on Wednesday. What to Expect.",
    "summary": "The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more and more heated.",
    "url": "https://www.barrons.com/articles/novo-nordisk-earnings-stock-price-997bc7ca?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ba684ec8-e1fe-37a7-b161-5472c35e891e",
      "content": {
        "id": "ba684ec8-e1fe-37a7-b161-5472c35e891e",
        "contentType": "STORY",
        "title": "Novo Nordisk Reports Earnings on Wednesday. What to Expect.",
        "description": "",
        "summary": "The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more and more heated.",
        "pubDate": "2025-11-04T21:30:00Z",
        "displayTime": "2025-11-04T21:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ba684ec8-e1fe-37a7-b161-5472c35e891e/novo-nordisk-reports-earnings.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xyHlGWIyozQ11qgbu0Gisw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N2uBceIjOWjhcBVcyJWYqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/novo-nordisk-earnings-stock-price-997bc7ca?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AKRO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:36:00+00:00",
    "headline": "Gastric Cancer Global and Regional Market Analysis 2025-2035: Focus on Treatment Type and End User with Profiles of Daiichi Sankyo, AstraZeneca, Roche, Merck & Co., Eli Lilly & Company and More",
    "summary": "Precision oncology is tailoring treatments based on molecular profiles, while new surgical and radiotherapy methods boost recovery. Despite challenges like late diagnosis and high treatment costs, leading pharmaceutical companies are driving therapeutic innovation. Strategic alliances and investments in clinical trials are expected to enhance access to new treatments globally.Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The \"Gastric Cancer Market - A Global and Regional Analysis: Focus on Treatment",
    "url": "https://finance.yahoo.com/news/gastric-cancer-global-regional-market-163600310.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "972253a1-a6cf-3316-9a90-3e289aed70dd",
      "content": {
        "id": "972253a1-a6cf-3316-9a90-3e289aed70dd",
        "contentType": "STORY",
        "title": "Gastric Cancer Global and Regional Market Analysis 2025-2035: Focus on Treatment Type and End User with Profiles of Daiichi Sankyo, AstraZeneca, Roche, Merck & Co., Eli Lilly & Company and More",
        "description": "",
        "summary": "Precision oncology is tailoring treatments based on molecular profiles, while new surgical and radiotherapy methods boost recovery. Despite challenges like late diagnosis and high treatment costs, leading pharmaceutical companies are driving therapeutic innovation. Strategic alliances and investments in clinical trials are expected to enhance access to new treatments globally.Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The \"Gastric Cancer Market - A Global and Regional Analysis: Focus on Treatment",
        "pubDate": "2025-11-04T16:36:00Z",
        "displayTime": "2025-11-04T16:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gastric-cancer-global-regional-market-163600310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gastric-cancer-global-regional-market-163600310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "ROG.SW"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "4568.T"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:45:04+00:00",
    "headline": "Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finance.yahoo.com/news/why-eli-lilly-lly-top-144504996.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c93d2937-f994-3c1f-88cd-bf703a5bf886",
      "content": {
        "id": "c93d2937-f994-3c1f-88cd-bf703a5bf886",
        "contentType": "STORY",
        "title": "Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term",
        "description": "",
        "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
        "pubDate": "2025-11-04T14:45:04Z",
        "displayTime": "2025-11-04T14:45:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wrLAPGGJOM4LTlpriDsibA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KPws6ZxoY5._RUBc.aqcuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-eli-lilly-lly-top-144504996.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-eli-lilly-lly-top-144504996.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:15:02+00:00",
    "headline": "International Markets and Lilly (LLY): A Deep Dive for Investors",
    "summary": "Explore how Lilly's (LLY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.",
    "url": "https://finance.yahoo.com/news/international-markets-lilly-lly-deep-141502131.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f4040a3f-7161-36d6-9c51-6f9cc242da4e",
      "content": {
        "id": "f4040a3f-7161-36d6-9c51-6f9cc242da4e",
        "contentType": "STORY",
        "title": "International Markets and Lilly (LLY): A Deep Dive for Investors",
        "description": "",
        "summary": "Explore how Lilly's (LLY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.",
        "pubDate": "2025-11-04T14:15:02Z",
        "displayTime": "2025-11-04T14:15:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2",
          "originalWidth": 900,
          "originalHeight": 741,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EYdBVn9rFNc9AepqcsmXXg--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2.cf.webp",
              "width": 900,
              "height": 741,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UC8YVzs0fyygH41RFBV7Qg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/international-markets-lilly-lly-deep-141502131.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/international-markets-lilly-lly-deep-141502131.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:00:06+00:00",
    "headline": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-140006824.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "bd9783b7-9567-37a0-9644-32c7178ca7a9",
      "content": {
        "id": "bd9783b7-9567-37a0-9644-32c7178ca7a9",
        "contentType": "STORY",
        "title": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
        "description": "",
        "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
        "pubDate": "2025-11-04T14:00:06Z",
        "displayTime": "2025-11-04T14:00:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295",
          "originalWidth": 900,
          "originalHeight": 506,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/76bXBMGd31NBsgLegGAr5w--~B/aD01MDY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295.cf.webp",
              "width": 900,
              "height": 506,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y3Fhh2cRRZ2a2ZMUABNaxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-140006824.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-attracting-140006824.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T13:00:00+00:00",
    "headline": "Family Heart Foundation® Launches New Initiative to Increase Understanding and Screening for High Lipoprotein(a), the Most Common Genetic Risk Factor for Premature Cardiovascular Disease",
    "summary": "FERNANDINA BEACH, Fla., November 04, 2025--The Family Heart Foundation, the leading research, education and advocacy organization focused on genetic dyslipidemias, has launched the Lp(a) AW(a)RETM initiative to engage key U.S. healthcare stakeholders in advancing awareness, screening and diagnosis of high Lipoprotein(a) – also known as Lp(a). It is estimated that approximately 20% of the U.S. population has a genetic mutation for high Lp(a), yet only 1% in the general population, and 2% with est",
    "url": "https://finance.yahoo.com/news/family-heart-foundation-launches-initiative-130000176.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "c610328c-71ac-3c24-b5c8-29182313fddd",
      "content": {
        "id": "c610328c-71ac-3c24-b5c8-29182313fddd",
        "contentType": "STORY",
        "title": "Family Heart Foundation® Launches New Initiative to Increase Understanding and Screening for High Lipoprotein(a), the Most Common Genetic Risk Factor for Premature Cardiovascular Disease",
        "description": "",
        "summary": "FERNANDINA BEACH, Fla., November 04, 2025--The Family Heart Foundation, the leading research, education and advocacy organization focused on genetic dyslipidemias, has launched the Lp(a) AW(a)RETM initiative to engage key U.S. healthcare stakeholders in advancing awareness, screening and diagnosis of high Lipoprotein(a) – also known as Lp(a). It is estimated that approximately 20% of the U.S. population has a genetic mutation for high Lp(a), yet only 1% in the general population, and 2% with est",
        "pubDate": "2025-11-04T13:00:00Z",
        "displayTime": "2025-11-04T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/44dee1d9f247cbf59868e340162db37e",
          "originalWidth": 480,
          "originalHeight": 230,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZURBei7i1KVsfeaxVu0voA--~B/aD0yMzA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/44dee1d9f247cbf59868e340162db37e.cf.webp",
              "width": 480,
              "height": 230,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.d7rvL0_cYlQ8qWm5EGXeA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/44dee1d9f247cbf59868e340162db37e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/family-heart-foundation-launches-initiative-130000176.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/family-heart-foundation-launches-initiative-130000176.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T12:45:00+00:00",
    "headline": "Is Eli Lilly a Millionaire Maker?",
    "summary": "Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.",
    "url": "https://www.fool.com/investing/2025/11/04/is-eli-lilly-a-millionaire-maker/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "27ccbfae-7962-330f-85b9-ef1a7cbd2a43",
      "content": {
        "id": "27ccbfae-7962-330f-85b9-ef1a7cbd2a43",
        "contentType": "STORY",
        "title": "Is Eli Lilly a Millionaire Maker?",
        "description": "",
        "summary": "Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.",
        "pubDate": "2025-11-04T12:45:00Z",
        "displayTime": "2025-11-04T12:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/271a6a79649854b7fc2e8c888b406d38",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "A person using an injection pen.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TRXT7qBYAd0bm0zLjEApsQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/271a6a79649854b7fc2e8c888b406d38.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ukwx7zHvTle87Vv7MYCkOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/271a6a79649854b7fc2e8c888b406d38.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/04/is-eli-lilly-a-millionaire-maker/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-millionaire-maker-124500168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T12:18:14+00:00",
    "headline": "Here’s What Weighed on Eli Lilly and Company’s (LLY) Performance",
    "summary": "Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 […]",
    "url": "https://finance.yahoo.com/news/weighed-eli-lilly-company-lly-121814097.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "48020227-5795-3374-b1e2-ce46a31a7a1b",
      "content": {
        "id": "48020227-5795-3374-b1e2-ce46a31a7a1b",
        "contentType": "STORY",
        "title": "Here’s What Weighed on Eli Lilly and Company’s (LLY) Performance",
        "description": "",
        "summary": "Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 […]",
        "pubDate": "2025-11-04T12:18:14Z",
        "displayTime": "2025-11-04T12:18:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/a9fb68fd7057548f7ce119cac6a87e1c",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Was Jim Cramer Right About Eli Lilly and Company (LLY)?",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DFQyzS.MgxX7FGup4wuuQQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a9fb68fd7057548f7ce119cac6a87e1c.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lop4Pg7FGZ0GE4bKJLODDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a9fb68fd7057548f7ce119cac6a87e1c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/weighed-eli-lilly-company-lly-121814097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/weighed-eli-lilly-company-lly-121814097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T09:47:41+00:00",
    "headline": "Eli Lilly to invest $3bn in new Dutch manufacturing facility",
    "summary": "Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist.",
    "url": "https://www.pharmaceutical-technology.com/news/lilly-dutch-facility/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "db70ce2f-315d-3da3-9c6b-77ba213ee141",
      "content": {
        "id": "db70ce2f-315d-3da3-9c6b-77ba213ee141",
        "contentType": "STORY",
        "title": "Eli Lilly to invest $3bn in new Dutch manufacturing facility",
        "description": "",
        "summary": "Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist.",
        "pubDate": "2025-11-04T09:47:41Z",
        "displayTime": "2025-11-04T09:47:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/41134eb6ef8b253c8980df52736df816",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "Lilly anticipates submitting regulatory filings for orforglipron as a treatment for obesity by this year end. Credit: Tada Images/Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tIK37vxRTJ3E6bjBSqjE7Q--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/41134eb6ef8b253c8980df52736df816.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4jGWNoiDTBKJmfq.o9jWmw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/41134eb6ef8b253c8980df52736df816.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/lilly-dutch-facility/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-invest-3bn-dutch-094741790.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T06:22:01+00:00",
    "headline": "Are Wall Street Analysts Predicting Eli Lilly Stock Will Climb or Sink?",
    "summary": "While the pharma giant Eli Lilly has lagged behind the broader market over the past year, it has outpaced the health care space, and analysts remain strongly bullish on the stock’s prospects.",
    "url": "https://www.barchart.com/story/news/35879320/are-wall-street-analysts-predicting-eli-lilly-stock-will-climb-or-sink",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "5ef4ccf3-c426-3207-8082-71be9d09707f",
      "content": {
        "id": "5ef4ccf3-c426-3207-8082-71be9d09707f",
        "contentType": "STORY",
        "title": "Are Wall Street Analysts Predicting Eli Lilly Stock Will Climb or Sink?",
        "description": "",
        "summary": "While the pharma giant Eli Lilly has lagged behind the broader market over the past year, it has outpaced the health care space, and analysts remain strongly bullish on the stock’s prospects.",
        "pubDate": "2025-11-04T06:22:01Z",
        "displayTime": "2025-11-04T06:22:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/b1ff4eb87fe0b23258b8460bf75e1ae8",
          "originalWidth": 1600,
          "originalHeight": 1068,
          "caption": "Eli Lilly and Co_ by Sergio Photone via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/q9zmeyuv_dVbQ1m3QSi.Og--~B/aD0xMDY4O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/barchart_com_477/b1ff4eb87fe0b23258b8460bf75e1ae8.cf.webp",
              "width": 1600,
              "height": 1068,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VsO6Ytv5wmTbEODj.QllxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/b1ff4eb87fe0b23258b8460bf75e1ae8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/35879320/are-wall-street-analysts-predicting-eli-lilly-stock-will-climb-or-sink",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-analysts-predicting-eli-062201349.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T22:20:00+00:00",
    "headline": "Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play",
    "summary": "Eli Lilly just posted its fastest revenue growth ever, putting shares up 40% in less than three months. The stock continues to have strong long-term potential.",
    "url": "https://www.marketbeat.com/originals/eli-lilly-posts-stellar-q3-long-term-upside-is-well-in-play/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "4d2a0a21-3d19-3f95-b196-2f7f18176b96",
      "content": {
        "id": "4d2a0a21-3d19-3f95-b196-2f7f18176b96",
        "contentType": "STORY",
        "title": "Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play",
        "description": "",
        "summary": "Eli Lilly just posted its fastest revenue growth ever, putting shares up 40% in less than three months. The stock continues to have strong long-term potential.",
        "pubDate": "2025-11-04T22:20:00Z",
        "displayTime": "2025-11-04T22:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/436888c334c94d33e974f4cee52cb117",
          "originalWidth": 1200,
          "originalHeight": 674,
          "caption": "Eli Lilly pills and injections",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Pv4sNiElsw.Au.MvtjPBBw--~B/aD02NzQ7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/436888c334c94d33e974f4cee52cb117.cf.webp",
              "width": 1200,
              "height": 674,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uYNouBvjk.1C2P3unbpjbA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/436888c334c94d33e974f4cee52cb117.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/originals/eli-lilly-posts-stellar-q3-long-term-upside-is-well-in-play/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-posts-stellar-q3-222000182.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T22:14:00+00:00",
    "headline": "Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, source says",
    "summary": "(Reuters) -Eli Lilly and Novo Nordisk are expected to announce deals with the Trump administration to cut prices of their weight-loss drugs in exchange for Medicare coverage, a White House source told",
    "url": "https://ca.finance.yahoo.com/news/lilly-novo-near-white-house-221400658.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "ee2b2349-6eb1-3d03-8dcf-8711ae031381",
      "content": {
        "id": "ee2b2349-6eb1-3d03-8dcf-8711ae031381",
        "contentType": "STORY",
        "title": "Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, source says",
        "description": "",
        "summary": "(Reuters) -Eli Lilly and Novo Nordisk are expected to announce deals with the Trump administration to cut prices of their weight-loss drugs in exchange for Medicare coverage, a White House source told",
        "pubDate": "2025-11-04T22:14:00Z",
        "displayTime": "2025-11-04T22:14:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/da558a36bc2201db1475f143593e7b85",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "A patient injects herself with her weekly dose of Wegovy in New Columbia, Pennsylvania, U.S., November 13, 2023. REUTERS/Hannah Beier/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0h1qQC_T60Ban0i_z6OcfQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/da558a36bc2201db1475f143593e7b85.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_mAoCUlgO..RfKhoU.AvVw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/da558a36bc2201db1475f143593e7b85.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/lilly-novo-near-white-house-221400658.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-novo-near-white-house-221400658.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]